menu ☰
menu ˟

Generic loteprednol etabonate approval tops OSN’s news of the week

27 Apr 2019
Here are some top stories on in the past week: FDA approves generic loteprednol etabonate from AkornThe FDA has approved an abbreviated new drug application for Akorn’s loteprednol etabonate ophthalmic suspension 0.5%. Read more. O...

Click here to view the full article which appeared in

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.